US OptionsDetailed Quotes

JNJ240712C150000

Watchlist

0.03
-0.40-93.02%

15min DelayClose Jul 12 16:00 ET

0.87High0.03Low

Johnson & Johnson Stock Discussion

Moomoo Breakfast US

11 hours ago

ColumnsWhat to Expect in the Week Ahead (GS, JNJ, TSM, and NFLX Earnings; Retail Sales and Housing Starts)

Earnings in the week ahead could be the next catalyst for a broadening market
$Johnson & Johnson(JNJ.US)$ is expected to announce its fiscal Q2 earnings before the markets open on Wednesday, July 17.
Ahead of the event, analysts expect Johnson & Johnson to report a profit of $2.73 per share, down 2.5% from $2.80 per share reported in the year-ago quarter. The company has consistently surpassed Wall...

US inflation cools again: Will it pave the way for a rate cut?

Stock_Drift

Jul 11 16:59

$Johnson & Johnson(JNJ.US)$

Phil Dunn

Jul 11 10:18

I am looking forward to upcoming Fed cuts

Big potiental for Russell 2000, REITs & Bond markets in second half year of 2024.
AI stocks may be struggling in short term but fundamentals are still very strong. A little pullback is normal.

US inflation cools again: Will it pave the way for a rate cut?

Mr Long Term

Jul 11 04:20

Columns3 Magnificent Dow Stocks That Are No-Brainer Buys for the Second Half of 2024.

For the last 128 years, the iconic Dow Jones Industrial Average $Dow Jones Industrial Average(.DJI.US)$ has served as the premier health barometer for Wall Street. What began as a 12-stock index that primarily contained industrial companies has transformed into a 30-component index comprised of time-tested, multinational businesses that have consistently delivered for investors over the long run.
While most Dow Jones stocks aren't...

Jessica Amir

Jul 8 02:51

ColumnsOn Ausbiz I covered Buy Hold or Sell: Nike, ASML, Micron Tech, JNJ, Constellation Energy, John Deere, Crowdstrike, Eli Lilly, Duolingo, Tesla, JP Morgan

It was great to be on Ausbiz, 'the call, with Ted Alexander from BML Funds and Nadine Blayney today.
I was asked about my thinking on the mentioned 11 US stocks. I presented a brief summary of my deep research dive, looking at company fundamentals and technical indicators, while considering macroeconomic policy, trends, government stimulus, clean...

On Ausbiz I covered Buy Hold or Sell: Nike, ASML, Micron Tech, JNJ, Constellation Energy, John Deere, Crowdstrike, Eli Lilly, Duolingo, Tesla, JP Morgan

Herd on Wall Street: mooving news stories and updates!

Brianjh

Jun 21 05:52

The Most Held Stocks by Hedge Funds

The whales ....
$Microsoft(MSFT.US)$ $Amazon(AMZN.US)$ $Alphabet-C(GOOG.US)$ $Apple(AAPL.US)$ $Meta Platforms(META.US)$ $NVIDIA(NVDA.US)$ $Visa(V.US)$ $JPMorgan(JPM.US)$ $Berkshire Hathaway-B(BRK.B.US)$ $MasterCard(MA.US)$ $UnitedHealth(UNH.US)$ $Johnson & Johnson(JNJ.US)$ $Exxon Mobil(XOM.US)$ $Eli Lilly and Co(LLY.US)$

Cow Moo-ney

Jun 14 06:13

Shorties

Wonder if anyone is shorting the market now? Whenever there is a small pullback, buyers will step in to push the market up.
It’s crazy how many record highs we have seen this year
$Alibaba(BABA.US)$ $Tesla(TSLA.US)$ $NIO Inc(NIO.US)$ $Super Micro Computer(SMCI.US)$ $NVIDIA(NVDA.US)$ $ARK 21Shares Bitcoin ETF(ARKB.US)$ $Johnson & Johnson(JNJ.US)$ $Arm Holdings(ARM.US)$ $Alphabet-A(GOOGL.US)$ $Apple(AAPL.US)$ $Amazon(AMZN.US)$ $Netflix(NFLX.US)$

https://youtu.be/TXubyY_yQRA

From YouTube

Meltyy

Jun 14 01:35

🚨 M&A Update! 🚨

Keep an eye on these recently announced M&As: 👀
$Merck & Co(MRK.US)$ to acquire EyeBio
$Biogen(BIIB.US)$ to acquire HI-Bio™
$Johnson & Johnson(JNJ.US)$ to acquire Proteologix
OnKure, Inc. merger with $Reneo Pharmaceuticals(RPHM.US)$
$Novartis AG(NVS.US)$ to acquire Mariana Oncology
What companies will be next? 🤔

Borneo AI Guy

Jun 12 18:41

$S&P 500 Index(.SPX.US)$ $Johnson & Johnson(JNJ.US)$

Cerealbox

Jun 6 23:05

$Johnson & Johnson(JNJ.US)$ has been under pressure due to talc lawsuits alleging its talc products cause ovarian cancer. In May, the company proposed a $6.5 billion settlement to resolve these claims. Despite this, J&J remains a top dividend stock with a 3.37% yield and has increased its dividend for 62 consecutive years. It has a forward P/E ratio of 13.79 makes it undervalued compared to the broader market. However, the firm does have more than forty new products in late stage clinical trials...

No comment yet